| Urothelial Carcinoma | Renal Cell Carcinoma | Control | ||
---|---|---|---|---|---|
Metastases-free | Metastases | Metastases-free | Metastases | ||
Number of Patients | 31 (♂ 22, ♀ 9) | 7 (♂ 4, ♀ 3) | 50 (♂ 35, ♀ 15) | 44 (♂ 30, ♀ 14) | 21 (♂ 15, ♀6) |
Age | 69 [57.5, 73.5] | 71 [70.5, 71.5] | 65.2 [56.9, 73.2] | 63.1 [55.3, 69.2] | 66 [61, 73] |
TNM classification | CIS, Ta, T1–3 N0, M0 | Ta, T1–3 N+/M+ | T1a-3c N0–1 M0 | T1a-4 N0–2 M0–2 | – |
Hgb (g/dl) | F: 12.9 [10.9, 13.9] M: 13.8 [13.2, 14.4] | F: 10.7 [10.6, 11.9] M: 13.8 [12.5, 14.3] | F: 13.3 [12.8, 14.4] M: 14.5 [12.8, 15.5] | F: 11.6 [10.7, 12.9] M: 14.2 [12.6, 14.7] | F: 13.6 [12.9, 14.2] M: 14.9 [14.5, 15.9] |
Hepcidin (ng/ml) | 36.4 [19.1, 113.3] | 59.6 [46.7, 110.8] | 8.2 [4, 18.4] | 18 [8.3, 35.3] | 5.8 [3.9, 11.2] |
GDF-15 (pg/ml) | 2039.4 [1360.9, 3215.2] | 4342.3 [3448, 6406.6] | 934.6 [687.1, 1711.2] | 1742.6 [989.1, 2690.1] | 754.3 [601.3, 987.7] |
Relapse | 12 | 5 | 0 | 39 | – |